Inventor · disambiguated record
Ioana Lovinger
Also filed as: LOVINGER IOANA
6 granted patents·10 pending applications·23 citations·filing 2004–2023
77Inventor score
Top patents by PatentIndex Score
16 records- 0190US8178127B2Stable laquinimod preparationsSAFADI MUHAMMAD·Filed 2008·Granted May 15, 2012·18 cites·16 claims
- 0277US8545885B2Stable laquinimod preparationsSAFADI MUHAMMAD·Filed 2012·Granted Oct 1, 2013·3 cites·20 claims
- 0377US2024041855A1Modified release formulations of pridopidinePrilenia Neurotherapeutics Ltd·Filed 2023·Application pending·0 cites
- 0476US11452694B2High concentration dosage forms of pridopidinePrilenia Neurotherapeutics Ltd·Filed 2020·Granted Sep 27, 2022·1 cites·26 claims
- 0569US8022104B2Formulations of ladostigil tartrateYISSUM RES DEV CO·Filed 2006·Granted Sep 20, 2011·1 cites·11 claims
- 0661US9340307B2Stable laquinimod preparationsTEVA PHARMA·Filed 2013·Granted May 17, 2016·0 cites·15 claims
- 0752US2019209542A1Modified release formulations of pridopidinePRILENIA THERAPEUTICS DEV LTD·Filed 2018·Application pending·0 cites
- 0852US2004175423A1Sustained release formulation of N- (2-propylpentanoyl) glycinamide and related compoundsFiled 2004·Application pending·0 cites
- 0948US9284276B2N-ethyl-N-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide, preparation and uses thereofIOFFE VLADIMIR·Filed 2013·Granted Mar 15, 2016·0 cites·17 claims
- 1043US2015202302A1Modified release formulations of pridopidineLICHT DANIELLA·Filed 2015·Application pending·0 cites
- 1142US2017065576A1N-ethyl-n-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide, preparation and uses thereofIOFFE VLADIMIR·Filed 2016·Application pending·0 cites
- 1241US2011301234A1Formulations of ladostigil tartrateLICHT DANIELLA·Filed 2011·Application pending·0 cites
- 1340US2016151345A1N-ethyl-n-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide, preparation and uses thereofIOFFE VLADIMIR·Filed 2016·Application pending·0 cites
- 1440US2016151346A1N-ethyl-n-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide, preparation and uses thereofIOFFE VLADIMIR·Filed 2016·Application pending·0 cites
- 1538US2017020854A1Pridopidine base formulations and their useLICHT DANIT·Filed 2016·Application pending·0 cites
- 1634US2014018386A1Laquinimod formulations without alkalizing agentSARFATI GADI·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →